-
Teprotumumab
-
BD015790451036734-93-695%
-
¥1800.01mg
-
7,10-Diphenyl-3,4a,5,5a,8a,9,9a,10-octahydro-5,9-methanothiazolo[5',4':5,6]thiopyrano[2,3-f]isoindole-2,6,8(7H)-trione
-
BD013068491217616-61-998%
-
¥1000.05mg
-
N-(4-((5-(3-Benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxybenzyl)oxy)phenyl)acetamide
-
BD011071421186649-91-198%
-
¥3798.0100mg
-
2-(3-((2,6-Dimethylphenoxy)methyl)-4-methoxyphenyl)-3-(pyridin-3-ylmethyl)-2,3-dihydroquinazolin-4(1H)-one
-
BD011837561338824-20-698%
-
¥2405.05mg
-
N-(1-Phenylethyl)-2-(piperazin-1-yl)quinazolin-4-amine
-
BD01093864662164-09-298%
-
¥743.050mg
-
Benzyl 6-methyl-2-oxo-4-(4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
-
BD01404019512840-45-8
-
¥
-
Org41841
-
BD00730351301847-37-098%
-
¥59072.0100mg
-
TSHR antagonist S37a
-
BD013166002143452-20-298%
-
¥
-
TSHR antagonist S37b
-
BD012725352143452-22-498%
-
¥
-
N-Methyl-4-(2-phenyl-1H-indol-3-yl)thiazol-2-amine
-
BD013743131171341-19-798%
-
¥